JP Morgan Chase’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,304,636
Closed -$157M 7430
2022
Q3
$157M Buy
2,304,636
+1,898,523
+467% +$105M 0.02% 566
2022
Q2
$13M Buy
406,113
+220,883
+119% +$6.47M ﹤0.01% 1951
2022
Q1
$6.42M Buy
185,230
+14,774
+9% +$442K ﹤0.01% 2783
2021
Q4
$4.99M Buy
170,456
+117,734
+223% +$3.65M ﹤0.01% 3060
2021
Q3
$1.34M Sell
52,722
-5,197
-9% -$153K ﹤0.01% 4091
2021
Q2
$2.03M Sell
57,919
-690,704
-92% -$27M ﹤0.01% 3785
2021
Q1
$30.5M Buy
748,623
+43,678
+6% +$2.01M ﹤0.01% 1432
2020
Q4
$30.5M Buy
704,945
+48,510
+7% +$2.39M ﹤0.01% 1325
2020
Q3
$35.4M Sell
656,435
-85,599
-12% -$5.44M 0.01% 1154
2020
Q2
$46.8M Buy
742,034
+281,651
+61% +$19.3M 0.01% 915
2020
Q1
$23.5M Buy
460,383
+25,693
+6% +$1.72M 0.01% 1151
2019
Q4
$34.6M Buy
434,690
+3,895
+0.9% +$231K 0.01% 1179
2019
Q3
$20.9M Buy
430,795
+30,329
+8% +$1.58M ﹤0.01% 1548
2019
Q2
$21.6M Buy
400,466
+18,397
+5% +$1.06M ﹤0.01% 1520
2019
Q1
$20.2M Buy
382,069
+10,621
+3% +$522K ﹤0.01% 1528
2018
Q4
$15.2M Buy
371,448
+9,583
+3% +$359K ﹤0.01% 1690
2018
Q3
$13.8M Buy
361,865
+48,188
+15% +$2.13M ﹤0.01% 1946
2018
Q2
$14.2M Buy
313,677
+202,027
+181% +$9.2M ﹤0.01% 1862
2018
Q1
$5.39M Sell
111,650
-112,229
-50% -$6.26M ﹤0.01% 2517
2017
Q4
$8.81M Sell
223,879
-8,742
-4% -$327K ﹤0.01% 2224
2017
Q3
$6.86M Sell
232,621
-3,054
-1% -$85.9K ﹤0.01% 2302
2017
Q2
$6.45M Buy
235,675
+11,468
+5% +$341K ﹤0.01% 2299
2017
Q1
$8.26M Buy
224,207
+48,382
+28% +$1.22M ﹤0.01% 2067
2016
Q4
$2.54M Sell
175,825
-9,480
-5% -$167K ﹤0.01% 2914
2016
Q3
$4.27M Buy
185,305
+8,450
+5% +$161K ﹤0.01% 2362
2016
Q2
$2.94M Sell
176,855
-9,145
-5% -$184K ﹤0.01% 2598
2016
Q1
$2.95M Sell
186,000
-1,500
-0.8% -$26.7K ﹤0.01% 2505
2015
Q4
$6.06M Sell
187,500
-26,075
-12% -$1.13M ﹤0.01% 2101
2015
Q3
$9.01M Buy
+213,575
New +$10.1M ﹤0.01% 1845

Other funds holding GBT